BioNeutra Global Corporation (BGACF) Fair Value & Analysis
Consumer Defensive · US · Market cap $260K
Fair value as of: Jun 26, 2026
Analysis
BioNeutra Global Corporation (BGACF) currently trades at $0.0056, while our model-based Fair Value estimate is $0.0058 — implying the stock looks roughly 4.4% undervalued today. We read business quality at 89/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
About the company
BioNeutra Global Corporation engages in the research and development, production, and commercialization of food for nutraceutical, functional, and mainstream food and beverage products with a focus on oligosaccharides. The company offers isomalt oligosaccharide ingredients under the VitaFiber brand for human digestive health. It operates in Canada, the United States, Australia, New Zealand, European Union, and the Asia Pacific. The company is headquartered in Vancouver, Canada.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is BioNeutra Global Corporation (BGACF) undervalued?
What is the fair value of BGACF?
What is the quality score of BGACF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.